1-Visit Eye Screening Study for Individuals with Diabetes/Pre-Diabetes

San Francisco CA

Description

In the coming weeks, We will be conducting a 1-Visit study to evaluate the performance of an Automated Retinal Disease Assessment software for the detection of more than mild diabetic retinopathy and/or diabetic macular edema. Must be 22 years or over and have documented diagnosis of Type I or Type II Diabetes. Or meet one of these criteria: a) A1C level of at least 6.5. OR b) Fasting Plasma Glucose (FPG) of at least 126 mg/dL OR c) Oral Glucose Tolerance Test (OGTT) (2-hr PG) of at least 200 mg/dL OR d) Symptoms of hyperglycemia or hyperglycemic crisis with a RPG of at least 200 mg/dL. This is NOT A drug treatment. This study will collect retinal images from diabetic patients. Each participant will have their eyes dilated and 9 images taken for analysis with the imaging modality in place. Exclusion criteria: 1. Self-reported visual symptoms and persistent blurred vision (greater than 24 hours); including vision loss that cannot be corrected (e.g. with eye glasses). 2. Diagnosed with macular edema, any known retinopathy, radiation retinopathy, or retinal vein occlusion. 3. History of laser treatment of the retina or injections into either eye, or any history of retinal surgery. 4. Scheduled to undergo the following surgeries before completion of the study imaging: cataract surgery (including any related follow-up procedures) or vitrectomy. 5. Currently participating in an interventional study. 6. Participant has a condition that, in the opinion of the investigator, would preclude participation in the study (e.g., unstable medical status including blood pressure or glycemic control, microphthalmia or previous enucleation, etc.). 7. Participant is contraindicated for imaging by fundus imaging system used in the study; e.g. ● Participant is hypersensitive to light (side effect of medication or due to unknown etiology) ● Participant has undergone photodynamic therapy (PDT) ● Previous issues with dilation (angle closure, inability to dilate, allergy to dilation drops) 8. Known pregnancy or possibility of active pregnancy Subject compensation: $100 Gift Card at study completion Please also pass this on to friends and family who may qualify and are interested in joining this study. Thank you, SF Research Institute, 2435 Ocean Avenue, San Francisco, CA 94127